Expansion Opportunities EMEA headquarters in Zug and recent regional activity suggest Zimmer Biomet is actively expanding manufacturing and capabilities in Europe. Target potential large-hub hospitals and regional distributors in Ireland, Northern Europe, and broader Europe to align with their capacity growth and new facility plans.

Product Portfolio Growth Recent news around Z1 Femoral Hip System and acquisitions like Paragon 28 indicate a strategy to broaden reconstructive offerings and surgeon-focused tools. Sales potential exists in orthopedic centers seeking diverse implant options, instrumentation, and integrated solutions.

Strategic Acquisitions Acquisition activity suggests a push to consolidate complementary technologies and expand market share. Identify customers and prospects likely to shift to Zimmer Biomet’s broader portfolio, including advanced implants and orthogrid-like instrumentation.

Technology Enablement The tech stack and emphasis on dynamic intelligence (ZBEdge) point to a data-driven approach to outcomes and device performance. Leverage opportunities with hospitals pursuing value-based purchasing, digital workflows, and decision-support tools integrated with Zimmer Biomet products.

Key Partners & Leads With a global footprint servicing over 100 countries and a diverse client base, prioritize relationships with large healthcare providers, regional distributors, and academic centers involved in musculoskeletal research and surgeon training to accelerate adoption of new systems and extensions.